Intact Investment Management Inc. Medicenna Therapeutics Corp. Transaction History

Intact Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.79 - $1.32 $58,381 - $97,548	-73,900 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.26 - $1.92 $360,234 - $548,928	-285,900 Reduced 79.46%	73,900 $117,000
Q4 2021 Feb 11, 2022	SELL	$1.53 - $2.85 $39,474 - $73,530	-25,800 Reduced 6.69%	359,800 $752,000
Q1 2021 May 17, 2021	BUY	$3.5 - $4.56 $1.35 Million - $1.76 Million	385,600 New	385,600 $1.96 Million

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Intact Investment Management Inc. with notifications on news.